Q1 2017 Holdings
Filed 2017-05-15 | 60 holdings | $110.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $52.7M | 902,578 | 47.7% |
| Boston Scientific Corp(BSX) | COM | 101137107 | $29.8M | 1,200,099 | 27.0% |
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $11.8M | 681,892 | 10.7% |
| Charles RIV Labs Intl Inc(CRL) | COM | 159864107 | $10.9M | 121,307 | 9.9% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $2.7M | 90,700 | 2.4% |
| Aurinia Pharmaceuticals Inc(AUPH) | COM | 05156V102 | $1.0M | 140,243 | 0.9% |
| Array Biopharma Inc(ARRYEUR) | COM | 04269X105 | $114.1K | 12,765,862 | 0.1% |
| Penumbra Inc(PEN) | COM | 70975L107 | $86.3K | 1,034,408 | 0.1% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $81.1K | 11,375,852 | 0.1% |
| Puma Biotechnology Inc(PBYI) | COM | 74587V107 | $64.2K | 1,725,414 | 0.1% |
| Clovis Oncology Inc(CLVSEUR) | COM | 189464100 | $61.9K | 972,696 | 0.1% |
| Atara Biotherapeutics Inc(ATRAGBX) | COM | 046513107 | $56.2K | 2,734,118 | 0.1% |
| Molina Healthcare Inc(MOH) | COM | 60855R100 | $52.4K | 1,149,727 | 0.0% |
| Prothena Corp PLC(PRTA) | SHS | G72800108 | $47.4K | 849,483 | 0.0% |
| Seattle Genetics Inc | COM | 812578102 | $43.8K | 696,386 | 0.0% |
| Incyte Corp(INCY) | COM | 45337C102 | $41.1K | 307,723 | 0.0% |
| GW Pharmaceuticals PLC | ADS | 36197T103 | $40.2K | 332,544 | 0.0% |
| Alder Biopharmaceuticals Inc(ALDR1EUR) | COM | 014339105 | $39.7K | 1,909,886 | 0.0% |
| Xencor Inc(XNCR) | COM | 98401F105 | $38.1K | 1,592,526 | 0.0% |
| Wave Life Sciences LTD(WVE) | SHS | Y95308105 | $35.0K | 1,271,097 | 0.0% |
| Global Blood Therapeutics in | COM | 37890U108 | $34.4K | 934,343 | 0.0% |
| Oxford Immunotec Global PLC | ORD SHS | G6855A103 | $31.1K | 2,004,849 | 0.0% |
| Inc Resh Hldgs Inc | CL A | 45329R109 | $29.1K | 633,779 | 0.0% |
| Anthem Inc(ELV) | COM | 036752103 | $29.0K | 175,328 | 0.0% |
| Chimerix Inc(CMRXEUR) | COM | 16934W106 | $27.6K | 4,325,055 | 0.0% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $26.9K | 622,345 | 0.0% |
| Neuroderm LTD | ORD SHS | M74231107 | $24.5K | 924,304 | 0.0% |
| ICU MED Inc(ICUI) | COM | 44930G107 | $24.5K | 160,543 | 0.0% |
| Regenxbio Inc(RGNX) | COM | 75901B107 | $24.5K | 1,269,131 | 0.0% |
| Jounce Therapeutics Inc(JNCEEUR) | COM | 481116101 | $22.5K | 1,114,160 | 0.0% |
| Immunomedics Inc(IMMU) | COM | 452907108 | $21.9K | 3,380,846 | 0.0% |
| Patheon N V | SHS | N6865W105 | $21.8K | 826,843 | 0.0% |
| Diplomat Pharmacy Inc(DPLOEUR) | COM | 25456K101 | $20.0K | 1,254,342 | 0.0% |
| Endologix Inc | COM | 29266S106 | $19.7K | 2,717,394 | 0.0% |
| Express Scripts Hldg Co | COM | 30219G108 | $19.4K | 293,807 | 0.0% |
| Nanostring Technologies Inc(NSTGEUR) | COM | 63009R109 | $18.6K | 934,424 | 0.0% |
| LA Jolla Pharmaceutical Co(LJPC) | COM PAR $.0001 2 | 503459604 | $18.0K | 604,470 | 0.0% |
| Catalent Inc(CTLTEUR) | COM | 148806102 | $17.7K | 624,000 | 0.0% |
| Cascadian Therapeutics Inc | COM NEW | 14740B606 | $16.9K | 4,072,424 | 0.0% |
| Parexel Intl Corp | COM | 699462107 | $16.4K | 260,231 | 0.0% |
| Spectranetics Corp | COM | 84760C107 | $16.2K | 557,189 | 0.0% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $16.0K | 400,000 | 0.0% |
| Immunogen Inc(IMGNEUR) | COM | 45253H101 | $15.4K | 3,984,734 | 0.0% |
| Syros Pharmaceuticals Inc | COM | 87184Q107 | $15.2K | 952,740 | 0.0% |
| Ehealth Inc(EHTH) | COM | 28238P109 | $14.3K | 1,191,334 | 0.0% |
| Audentes Therapeutics Inc(BOLDEUR) | COM | 05070R104 | $14.0K | 820,836 | 0.0% |
| Array Biopharma Inc | NOTE 3.000% 6/0 | 04269XAA3 | $12.8K | $9,000,000 | 0.0% |
| Mckesson Corp(MCK) | COM | 58155Q103 | $11.6K | 78,300 | 0.0% |
| Invitae Corp(NVTA1EUR) | COM | 46185L103 | $9.0K | 812,240 | 0.0% |
| Model N Inc(MODNEUR) | COM | 607525102 | $8.6K | 822,314 | 0.0% |